| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Verve Therapeutics, Inc. | Director | Stock Option (right to buy) | 0 | 25 Jul 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| VERV | Verve Therapeutics, Inc. | 25 Jul 2025 | 3 | $0 | 4 | Director | 28 Jul 2025, 17:15 |
| VERV | Verve Therapeutics, Inc. | 05 Jun 2025 | 1 | $0 | 4 | Director | 06 Jun 2025, 17:00 |
| VERV | Verve Therapeutics, Inc. | 26 Jun 2024 | 1 | $0 | 4 | Director | 28 Jun 2024, 07:45 |
| VERV | Verve Therapeutics, Inc. | 15 Jun 2023 | 1 | $0 | 4 | Director | 20 Jun 2023, 17:00 |
| VERV | Verve Therapeutics, Inc. | 09 Jun 2022 | 1 | $0 | 4 | Director | 13 Jun 2022, 17:00 |
| VERV | Verve Therapeutics, Inc. | 16 Jun 2021 | 0 | $0 | 3 | Director | 16 Jun 2021, 19:38 |